Genzyme Division Taps McKay Fried

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.




BOSTON-McKay Fried & Partners here has picked up an advertising and public relations assignment from a newly formed unit of Genzyme Corp., a biotechnology company in Cambridge, Mass.
The agency has been retained by Genzyme Tissue Repair to handle the introduction of Carticel, a procedure soon to be marketed as an alternative to some current types of knee repair surgery.
The procedure is in the final stages of the federal regulatory approval process. Genzyme expects approval to be granted in the next few weeks, said company representative Susan Walker.
The client plans to launch Carticel through a nationwide advertising and public relations campaign before year’s end, said Walker.





AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in